Test Price
2,800 AED✅ Home Collection Available
ALAS2 Gene Erythropoietic Protoporphyria, X‑Linked Genetic Test in UAE | 2800 AED
Executive Summary & Core Metrics
This advanced diagnostic genetic test delivers 99.9% analytical sensitivity via next‑generation sequencing (NGS) at our ISO 9001:2015 certified laboratory. The service includes hospital‑grade home collection through VIP mobile phlebotomy (8 AM–11 PM) with validated cold‑chain logistics, post‑result telephonic consultation from DHA‑licensed clinicians, and direct billing verification via WhatsApp.
Test Overview & Methodology
The ALAS2 Gene Erythropoietic Protoporphyria, X‑Linked Genetic Test detects gain‑of‑function mutations in the ALAS2 gene responsible for X‑linked erythropoietic protoporphyria (XLP). This comprehensive next‑generation sequencing test provides unambiguous molecular confirmation of the disease, guides photoprotection strategies, and enables proactive monitoring for hepatic complications.
| Feature | Our Test – ALAS2 NGS | Closest Alternative – Single‑Gene Sanger |
|---|---|---|
| Precision | 99.9% Analytical Sensitivity; full gene coverage including deep intronic and copy‑number variants | ~95% sensitivity for preselected exons; misses large deletions/duplications |
| Method | Next‑Generation Sequencing (NGS) with validated bioinformatics pipeline | Capillary Sanger sequencing of limited hotspots |
| Turnaround Time | 3–4 Weeks | 4–6 Weeks (often with batch delays) |
Physician Insight & Safety Protocols
“As a clinical geneticist committed to precise molecular diagnosis, I understand the profound impact a genetic result can have on a patient’s journey. A positive ALAS2 finding is not a limitation but a roadmap: paired with your clinical history and biochemical markers, it enables a customized care plan that significantly reduces photosensitivity episodes and supports long‑term hepatic surveillance. I, Lina Osama Zaki Quteineh (DHA: 9294403), assure you that our multidisciplinary team will guide you through every stage of interpretation and management.”
Advisory & Safety Notices
⚠ Medication Warning
Do not discontinue any prescribed medication without consulting your doctor. Unsupervised cessation may lead to complications unrelated to porphyria.
Exclusion Criteria & Emergency Red Flags
- Inability to provide a peripheral blood sample (e.g., severe coagulopathy not cleared by a physician).
- Known allergic reaction to standard phlebotomy materials; special arrangements must be made in advance.
- New‑onset severe abdominal pain, blistering skin lesions on sun‑exposed areas, or neurological changes → seek immediate emergency care, not a scheduled lab draw.
Patient FAQ & Clinical Guidance
1. What is the purpose of ALAS2 gene testing?
A precise genetic diagnosis for X‑linked erythropoietic protoporphyria helps tailor photoprotection and monitor long‑term liver health.
2. How long does it take to receive the results?
Results are typically available within 3 to 4 weeks, owing to extensive coverage analysis and confirmation of variants.
3. Is home blood collection safe and approved by the DHA?
Yes, our ISO‑certified mobile phlebotomy service follows DHA home healthcare standards and cold‑chain protocols.
UAE Regulatory & Data Privacy Adherence
This test is performed under DHA Facility License No. 1143 at DNA Labs UAE, Dubai Healthcare City. All genetic data handling complies with Federal Decree‑Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Our laboratory holds ISO 9001:2015 Certification (INT/EGQ/2509DA/3139). Clinical safety and patient consent adhere to Federal Decree‑Law No. 4 of 2016 on Medical Liability.
Clinical & Logistical Metadata
| Test Name | ALAS2 Gene Erythropoietic Protoporphyria, X‑Linked Genetic Test |
| Price (AED) | 2,800 |
| Turnaround Time | 3–4 Weeks |
| Sample Type / Matrix | Peripheral Whole Blood |
| Methodology Used | Next‑Generation Sequencing (NGS) |
| ICD-10-CM Code | E80.0 (Erythropoietic protoporphyria) |
| LOINC Code | 21672-8 (ALAS2 gene mutation analysis) |
| DHA Facility License & Laboratory Address | DHA License 1143 – Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE – DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians